Jolanta Airey
Vermögen: - $ am 31.07.2026
Vermögen: - $ am 31.07.2026
Dr. Jolanta Airey was previously employed as a Chief Medical Officer by Cynata Therapeutics Ltd., a Director-Translational Development by CSL Ltd., and a Head-Clinical Development Physician by CSL Seqirus Inc. She received her doctorate degree from Vilnius University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.06.2025 | 0 ( -.--% ) | - $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ACRUX LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 24.08.2026 |
| Unternehmen | Position | Ende |
|---|---|---|
| CYNATA THERAPEUTICS LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2026 |
| CSL LIMITED | Corporate Officer/Principal | 01.10.2021 |
Csl Seqirus
Csl Seqirus BiotechnologyHealth Technology Manufactures influenza vaccine products | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
CSL Ltd.
CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Acrux Ltd.
Acrux Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Vilnius University
Vilnius University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cynata Therapeutics Ltd.
Cynata Therapeutics Ltd. BiotechnologyHealth Technology Engages in stem cell research and development services | Health Technology |
Csl Seqirus
Csl Seqirus BiotechnologyHealth Technology Manufactures influenza vaccine products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen